RBC Capital cuts Amgen stock price target to $320 from $324
RBC Capital Markets adjusted its price target for Amgen (NASDAQ:AMGN) shares, reducing it slightly from $324 to $320, while retaining an Outperform rating on the biotechnology firm's stock. The ...
RBC raises AECOM stock price target to $125, maintains Outperform
RBC Capital Markets adjusted its outlook on AECOM Technology (NYSE:ACM), raising the firm's price target on the shares to $125 from $124, while reiterating an Outperform rating. The decision came ...